By Phase

Preclinical

Your Partner for Preclinical Research and Development with One-Stop Platform and Solutions

Take Your Preclinical Research to the Next Level

We are committed to providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science innovation. Using state-of-the-art technologies, a global network of facilities, and a “Two Countries, One System” approach, we move customers’ research project to the next level and ensure that all testing meets worldwide standards for quality and compliance.

  • Operating in China and US with synchronized SOPs and quality standards.
  • A comprehensive portfolio of laboratory services ranging from drug discovery to IND enabling package
  • Strong track record of successful regulatory inspections by US FDA, NMPA, WHO and US EPA, etc.
  • Strong global management and technical team, experienced in GMP, GLP, GCP, 100+ US/CN audits
  • AAALAC accredited animal facilities

Explore Our Preclinical Service Portfolio

Bioanalytical lab inspections by NMPA
120+
Global customers
700+
Lab inspections by US FDA
50+
25k+
Compounds delivered

Early Phase Drug Discovery Platform

Medicinal Chemistry

  • Drug Molecular Design
  • Hit to lead
  • Quality Research
  • Customized Synthesis

Drug Screening

  • Enzymatic assays
  • Cell based assays
  • Recombinant cell line assays
  • Early MOA
  • Customized Assay validation

DMPK

  • In vitro plasma protein binding screening
  • In vitro metabolic stability
  • In vitro transporter studies
  • in vitro metabolic enzymes Studies 
  • Metabolic soft spot analysis
  • In vivo pharmacokinetic screening

IND Enabling Platform

Laboratories in US and China

Quality, Scientific Integrity, Regulatory Compliance

Let's Connect for a Conversation